<DOC>
	<DOCNO>NCT00907530</DOCNO>
	<brief_summary>This study conduct phase IV , double-blind , multi-center , randomize , crossover trial aim within-subject comparison MULTIHANCE GADOVIST dose 0.1 mmol/kg , term qualitative quantitative assessment unenhanced MRI ( UE MRI ) contrast-enhanced MRI ( CE MRI ) visualization brain disease .</brief_summary>
	<brief_title>Study Compare MultiHance With Gadovist Magnetic Resonance Imaging ( MRI ) Brain</brief_title>
	<detailed_description />
	<criteria>Enroll subject study meet follow inclusion criterion : Are least 18 year age old Are able give write informed consent willing comply protocol requirement Are schedule undergo MRI Are willing undergo two MRI procedure within 14 day Have confirm highly suspect brain tumor ( ) ( primary secondary ) , determine : clinical/neurological symptomatology ; diagnostic testing , CT previous MRI examination ; recent surgery within 6 month evaluate recurrence . Exclude subject study fulfill inclusion criterion , follow condition observe . Are pregnant lactate female . Exclude possibility pregnancy : test site institution ( serum urine bHCG ) within 24 h prior start investigational product administration history ( i.e. , tubal ligation hysterectomy ) post menopausal minimum 1 year without menses Have know allergy one ingredients investigational product , history hypersensitivity metal Have congestive heart failure ( class IV accord classification New York Heart Association Have suffer stroke within year Have receive schedule receive contrast medium 24 h precede 24 h follow Exam 1 , 24 h precede 24 h follow Exam 2 Have receive schedule receive investigational compound and/or medical device within 30 day admission present study , 24 h postadministration second investigational product . Have moderatetosevere renal impairment , define GFR/eGFR &lt; 60 mL/min . Have previously enter study Have receive schedule one following : Surgery within three week prior first examination two examination Initiation steroid therapy two examination Radiosurgery two examination Have contraindication MRI pacemaker , magnetic material ( i.e. , surgical clip ) condition would preclude proximity strong magnetic field . Are suffer severe claustrophobia Have medical condition circumstance would significantly decrease chance obtain reliable data , achieve study objective , complete study and/or postdose followup examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>